Headlines

NASDAQ:CLVS

NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Mark Doerr02 mins

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume…

Read More
FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox02 mins

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average…

Read More

Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)

Jason Knox03 mins

Pingtan Marine Enterprise Ltd. (NASDAQ:PME) announced that the Company has declared a cash dividend of $0.01 per share of common stock outstanding, payable in cash on or about February 18, 2015 to shareholders of record on January 22, 2015. This marks the second consecutive quarterly dividend paid by the Company, which it intends to continue…

Read More
Home